|
Anika Therapeutics, Inc. - Company Profile Snapshot
| Company Profile: |
Anika Therapeutics, Inc. |
| Ticker: |
ANIK |
| Exchanges: |
NAS |
| 2008 Sales: |
35,780,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
84 |
Business Description
Anika Therapeutics, Inc.. The Group's principal activities are to develop, manufacture and distribute therapeutic products and devices. The products promote the protection healing and repair. The Group's products include ORTHOVISC (R), which is based on hyaluronic acid (HA), used in the treatment of some forms of osteoarthritis in humans and HYVISC (R), used in the treatment of equine osteoarthritis. ORTHOVISC (R) is currently marketed in Canada, Europe, Turkey and parts of the Middle East. The Group also manufactures AMVISC (R) and AMVISC (R) plus for Bausch & Lomb, which are used as viscoelastic supplements in ophthalmic surgery.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
